Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares China Large-Cap ETF
FXI
|
+$40.5M |
| 2 |
S&P Global
SPGI
|
+$30.2M |
| 3 |
Medtronic
MDT
|
+$25.3M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
+$23.2M |
| 5 |
Northrop Grumman
NOC
|
+$20.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$63.7M |
| 2 |
Conagra Brands
CAG
|
+$20.3M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$20M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$18.2M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$15.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 13.74% |
| 2 | Healthcare | 12.91% |
| 3 | Technology | 11.18% |
| 4 | Consumer Discretionary | 11.04% |
| 5 | Industrials | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CYNO
1251
DELISTED
Cynosure, Inc. Class A
CYNO
| $257K | 0.01% |
+5,629
| New | +$258K |
2016 Q4
0 quarters
|
|
1252
Aptiv
APTV
$7.84B
| $256K | 0.01% |
+3,801
| New | +$255K |
2016 Q4
0 quarters
|
|
1253
AstraZeneca
AZN
$286B
| $256K | 0.01% |
+4,692
| New | +$266K |
2016 Q4
0 quarters
|
|
1254
Easterly Government Properties
DEA
$1.04B
| $256K | 0.01% |
+5,122
| New | +$245K |
2016 Q4
0 quarters
|
|
1255
Kestrel Group
KG
$29.4M
| $256K | 0.01% |
734
+11
| +2% | +$3.37K |
2016 Q3
1 quarter
|
|
|
IPHS
1256
DELISTED
Innophos Holdings, Inc.
IPHS
| $255K | 0.01% |
+4,870
| New | +$237K |
2016 Q4
0 quarters
|
|
|
OME
1257
DELISTED
Omega Protein
OME
| $255K | 0.01% |
+10,195
| New | +$241K |
2016 Q4
0 quarters
|
|
1258
DELISTED
Accelerate Diagnostics
AXDX
| $254K | 0.01% |
+1,224
| New | +$291K |
2016 Q4
0 quarters
|
|
|
CCMP
1259
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $254K | 0.01% |
+4,023
| New | +$233K |
2016 Q4
0 quarters
|
|
1260
Customers Bancorp
CUBI
$2.84B
| $252K | 0.01% |
+7,026
| New | +$208K |
2016 Q4
0 quarters
|
|
1261
HealthEquity
HQY
$8.56B
| $252K | 0.01% |
+6,212
| New | +$240K |
2016 Q4
0 quarters
|
|
|
FNHC
1262
DELISTED
FedNat Holding Company Common Stock
FNHC
| $252K | 0.01% |
+13,495
| New | +$239K |
2016 Q4
0 quarters
|
|
|
AGU
1263
DELISTED
Agrium
AGU
| $252K | 0.01% |
+2,507
| New | +$242K |
2016 Q4
0 quarters
|
|
|
CACB
1264
DELISTED
Cascade Bancorp
CACB
| $252K | 0.01% |
+31,000
| New | +$215K |
2016 Q4
0 quarters
|
|
1265
Zumiez
ZUMZ
$215M
| $251K | 0.01% |
+11,494
| New | +$266K |
2016 Q4
0 quarters
|
|
|
EBSB
1266
DELISTED
Meridian Bancorp, Inc.
EBSB
| $251K | 0.01% |
+13,259
| New | +$226K |
2016 Q4
0 quarters
|
|
1267
Nuveen New York Quality Municipal Income Fund
NAN
$330M
| $250K | 0.01% |
+18,600
| New | +$258K |
2016 Q4
0 quarters
|
|
1268
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.32B
| $250K | 0.01% |
+19,800
| New | +$248K |
2016 Q4
0 quarters
|
|
1269
Expro Ltd
XPRO
$1.51B
| $249K | 0.01% |
+3,367
| New | +$247K |
2016 Q4
0 quarters
|
|
|
FRC
1270
DELISTED
First Republic Bank
FRC
| $249K | 0.01% |
+2,700
| New | +$220K |
2016 Q4
0 quarters
|
|
1271
ANI Pharmaceuticals
ANIP
$1.62B
| $248K | 0.01% |
4,088
+184
| +5% | +$11.3K |
2016 Q3
1 quarter
|
|
1272
Granite Construction
GVA
$5.5B
| $248K | 0.01% |
+4,508
| New | +$239K |
2016 Q4
0 quarters
|
|
|
STBZ
1273
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $248K | 0.01% |
+9,232
| New | +$225K |
2016 Q4
0 quarters
|
|
|
SPHS
1274
DELISTED
Sophiris Bio, Inc.
SPHS
| $248K | 0.01% |
+88,600
| New | +$251K |
2016 Q4
0 quarters
|
|
1275
Kforce
KFRC
$1B
| $247K | 0.01% |
+10,694
| New | +$220K |
2016 Q4
0 quarters
|
|
Similar funds
Squarepoint's Q4 2016 Portfolio in Review
As of Q4 2016, Squarepoint held 2,060 positions worth $2.44B, up 62% from $1.51B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Squarepoint deployed $913M of net new capital in Q4 2016, opening 1,079 new positions and adding to 424 existing holdings. Its largest new stake was S&P Global: 252,484 shares worth $27.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 14% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Conagra Brands, an estimated $20.3M trimmed.
- Squarepoint's largest Q4 2016 buy was S&P Global: 252,484 shares worth $27.2M.
- Squarepoint added most to iShares China Large-Cap ETF in Q4 2016, an estimated $40.5M increase.
- Squarepoint's biggest Q4 2016 reduction was Conagra Brands, cutting an estimated $20.3M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q4 2016, selling an estimated $63.7M.
- Squarepoint's ten largest holdings make up 9.6% of its $2.44B portfolio in Q4 2016.
- Squarepoint opened 1,079 new positions and closed 329 in Q4 2016.
- Squarepoint's portfolio value rose 62% quarter-over-quarter to $2.44B.
Based on Squarepoint's 13F filing for Q4 2016, filed 14 Feb 2017.